Transplant Conditioning With Treosulfan/Fludarabine With or Without TBI. A Randomized Phase II Trial in Patients With MDS and AML
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2017.12.785
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2018
Authors
Publisher
Elsevier BV